RGNX (STOCKS)
REGENXBIO Inc.
$9.190000
+0.390000 (+4.43%)
Prev close: $8.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Curran M. Simpson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $465.91M
- Employees
- 353
- P/E (TTM)
- -2.41
- P/B (TTM)
- 4.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.30 | $-0.98 | -0.3248 | -33.31% |
|
Sep 2025 (Q3)
|
$-1.20 | $-1.33 | +0.1316 | +9.88% |
|
Jun 2025 (Q2)
|
$-1.38 | $-1.12 | -0.2580 | -22.99% |
|
Mar 2025 (Q1)
|
$0.12 | $0.49 | -0.3724 | -75.63% |
Financial Statements
| Revenues | $170.44M |
| Benefits Costs and Expenses | $364.32M |
| Costs And Expenses | $331.64M |
| Nonoperating Income/Loss | -$32.68M |
| Operating Expenses | $331.64M |
| Depreciation and Amortization | $15.62M |
| Research and Development | $228.30M |
| Other Operating Expenses | $87.73M |
| Operating Income/Loss | -$161.20M |
| Income/Loss From Continuing Operations After Tax | -$193.88M |
| Income/Loss From Continuing Operations Before Tax | -$193.88M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$193.88M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$193.88M |
| Net Income/Loss Available To Common Stockholders, Basic | -$193.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.76 |
| Diluted Earnings Per Share | -$3.76 |
| Basic Average Shares | 51,573,000 |
| Diluted Average Shares | 51,573,000 |
| Assets | $453.03M |
| Current Assets | $281.28M |
| Cash | $240.90M |
| Accounts Receivable | $26.38M |
| Prepaid Expenses | $11.93M |
| Other Current Assets | $2.08M |
| Noncurrent Assets | $171.75M |
| Fixed Assets | $104.86M |
| Other Non-current Assets | $66.90M |
| Liabilities | $350.30M |
| Current Liabilities | $118.10M |
| Accounts Payable | $21.36M |
| Wages | $17.42M |
| Other Current Liabilities | $79.32M |
| Noncurrent Liabilities | $232.20M |
| Equity | $102.73M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $102.73M |
| Liabilities And Equity | $453.03M |
| Net Cash Flow From Operating Activities | -$123.96M |
| Net Cash Flow From Operating Activities, Continuing | -$123.96M |
| Net Cash Flow From Investing Activities | -$15.87M |
| Net Cash Flow From Investing Activities, Continuing | -$15.87M |
| Net Cash Flow From Financing Activities | $116.77M |
| Net Cash Flow From Financing Activities, Continuing | $116.77M |
| Net Cash Flow | -$23.06M |
| Net Cash Flow, Continuing | -$23.06M |
| Comprehensive Income/Loss | -$193.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$193.82M |
| Other Comprehensive Income/Loss | $54.00K |